OR WAIT null SECS
September 16, 2022
The White House hopes to expand US modern biotech manufacturing and reduce reliance on foreign sources of bioindustrial materials.
September 14, 2022
Emergence Therapeutics will work with Synaffix’s ADC technology platform to develop multiple ADCs against undisclosed targets.
September 09, 2022
Salipro has been granted patents in the United States and China for its proprietary technology to enable the development of therapeutics against challenging drug targets.
Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.
September 08, 2022
Roche’s acquisition of Good Therapeutics grants them rights to the company's conditionally activated PD-1-regulated IL-2 program.
September 07, 2022
SIRIO is enhancing its strategy for small and medium nutrition brands as Lonza’s Sara Lesina joins as GM in Europe.
September 03, 2022
The flow of capital and scientific acuity irrigates this pharm system.
September 02, 2022
Novo Nordisk’s $1.1 billion acquisition of Forma Therapeutics is intended to expand its sickle cell and rare blood disorder portfolio.
Pharma loses battle to block price negotiations, but implementation faces many challenges.
While the cost of certain medicines are alarmingly high, they can be considered a bargain measured against a lifetime of traditional costs.